Global Minimally Invasive Surgery Devices Market Report 2022

New York, May 27, 2022 (GLOBE NEWSWIRE) — announces the release of the “Minimal Invasive Surgery Devices Global Market Report 2022” –
Braun Melsung AG.

The global minimally invasive surgery devices market is expected to grow from $26.04 billion in 2021 to $28.98 billion in 2022 at a compound annual growth rate (CAGR) of 11.3%. The market is expected to reach $36.61 billion in 2026 at a compound annual growth rate (CAGR) of 6%.

The minimally invasive surgical devices market consists of sales of minimally invasive surgical devices and related services. Minimally invasive surgery devices are used to minimize surgical incisions and trauma to the body.

The main product types of minimally invasive surgery devices are hand-held instruments, inflation devices, cutting instruments, guiding devices, electrosurgical devices, auxiliary devices, monitoring and viewing devices. Electrosurgical devices are used to destroy tissue, incise tissue, and control bleeding by coagulation. some blood.

The various applications of minimally invasive surgery devices are laparoscopy, cardiovascular surgery, cosmetic surgery, orthopedic surgery, obstetrics and gynecology, ophthalmology, neurosurgery, urology and others which are used by end users such as hospitals, Ambulatory Surgical Centers (ASCS), and research institutes.

Rising awareness of minimally invasive surgeries among people is driving the minimally invasive surgery devices market. risk of bleeding and infections, and low tissue damage.

According to the German Cardiac Surgery Report, cardiac operations using ECC (extracorporeal circulation) have declined due to the achievement of established innovations in minimally invasive treatment options in cardiac surgeries. In addition, 51.1% of heart valve operations performed out of the total number of heart surgeries in Germany were performed by the single-valve procedure, of which 38.5% by minimally invasive heart surgeries. Thus, the growing demand for minimally invasive surgery (MIS) will increase the demand for the minimally invasive surgical devices market.

Rising trade barriers are expected to negatively impact the growth of the Minimally Invasive Surgery Devices market. Many countries have imposed trade restrictions, especially on imports, to stimulate local production.

For example, Brexit is likely to lead to more trade restrictions between the UK and other countries in Europe. The United States is also putting in place several trade restrictions, particularly with China, to boost its local production.

For example, the US government imposed an additional 25% tariff on approximately $16 billion worth of imports from China, including minimally invasive surgical devices, equipment and supplies. These trade restrictions are likely to limit demand growth in the future by driving up prices.

Technologically advanced minimally invasive surgery (MIS) devices with improvements in image guidance, fiber optics, mini dental implants and robotic control systems are increasingly chosen by patients to treat conditions medical procedures such as aneurysms, cardiac procedures, dental and spinal procedures. Less-invasive surgical procedures with enhanced capabilities in the areas of imaging, micro-machining, robotic equipment and components, systems software and the like are becoming popular in the healthcare industry.

For example, video-assisted thoracoscopic surgery (VATS) is a minimally invasive surgical procedure performed to completely remove an organ from the human body to treat traumatic injury, infection, or cancer of the lungs. TVA is performed using a video camera where a small tube called a thoracoscope, to which the camera is connected, is inserted through a small incision between the ribs.

Also, the imaging technology involved in GIS, Virtual Reality (VR) is becoming an important area of ​​development. Other MIS techniques are applied to perform surgeries such as single site laparoscopic surgery, robotic surgeries, needle surgery, heart and spinal surgeries, etc.

The Food and Drug Administration Act (FDA) regulates the market for minimally invasive surgical devices in the United States of America. the hazards, if any, listed by the FDA.

In December 2019, the FDA issued a safety communication regarding caution when using minimally invasive robot-assisted surgical devices in women’s healthcare, including mastectomy and other cancer-related surgeries. However, the FDA is concerned that health care providers and patients are unaware of the safety and effectiveness of these devices, as they should not be used in mastectomy procedures or in the prevention or treatment of cancer.

Regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Countries covered in Minimally Invasive Surgery Devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the United Kingdom and the United States.

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.



Comments are closed.